ARCHIVES

FDA Nearly Wrecks NCI Drug Distribution Program, Finally Agrees To New Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 05 | January 30, 1976

Download PDF Visit The Full Archive

Related Articles

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

January 23, 2004

Millers, Jensen, Bereblum Win $100,000 GM awards

June 6, 1980

In Brief: Deadline June 1 For New ACS Prevention Awards; Money Available To Fund Five More

April 11, 1980

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

February 6, 1976